First Australia/New Zealand clinical guidance developed for people living with multiple sclerosis
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...
Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...
Cosmos Health files patent application for multiple sclerosis treatment
Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...
Medical News Today13d
Can Botox help manage MS symptoms?
Therefore, professionals usually reserve this treatment for cases where other multiple sclerosis treatment options, such as oral medications or physical therapy, have been ineffective. It is ...
Multiple Sclerosis News Today4d
In life with multiple sclerosis, you can’t wait until you get around to it
Columnist Ben Hofmeister, while searching for motivation in a life with multiple sclerosis, feels he just needs to get around to it.
Neurology Advisor1d
Women With Multiple Sclerosis Show Increased Migraine Risk Before Symptom Onset
Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...
EurekAlert!12d
National Multiple Sclerosis Society awards Dr. Mikael Simons with Barancik Prize for Innovation in MS Research
Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...
imt.ie10d
Neuraxpharm announces the launch of BRIUMVI (ublituximab) in Ireland for the treatment of relapsing multiple sclerosis
Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...